Tumorzentrum der Universität Erlangen-Nürnberg

AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer. (2024) Bannier PA, Saillard C, Mann P, Touzot M, Maussion C, Matek C, Klümper N, et al. Journal article A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status—results of a prospective multicenter phase II trial (DIREKHT Trial) (2024) Haderlein M, von der Grün J, Balermpas P, Rödel C, Hautmann MG, Steger F, Bohr C, et al. Journal article Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens. (2024) Baden D, Zukunft S, Hernandez G, Wolgast N, Steinhauser S, Pohlmann A, Schliemann C, et al. Journal article Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer (2024) Lange F, Geppert CI, Bahlinger V, Bertz S, Stöhr R, Sikic D, Taubert H, et al. Journal article Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center (2024) Winkler LS, Haderlein M, Semrau S, Putz F, Höfler D, Müller SK, Iro H, et al. Journal article Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts (2024) Bahlinger V, Branz A, Strissel P, Strick R, Lange F, Geppert CI, Klümper N, et al. Journal article The modified Polsby–Popper score, a novel quantitative histomorphological biomarker and its potential to predict lymph node positivity and cancer-specific survival in oral tongue squamous cell carcinoma (2023) Csűry TD, Csűry AZ, Balk M, Kist A, Rupp R, Müller SK, Sievert M, et al. Journal article RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer (2023) Behrens A, Wurmthaler L, Heindl F, Gaß P, Häberle L, Volz B, Hack C, et al. Journal article Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer (2023) Slamon DJ, Fasching P, Hurvitz S, Chia S, Crown J, Martín M, Barrios CH, et al. Journal article